ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,198, issued on Dec. 9, was assigned to VeroScience LLC (Tiverton, R.I.).
"Composition and method for treating metabolic disorders" was invented by Anthony H. Cincotta (Tiverton, R.I.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Bromocriptine citrate administered to a vertebrate, animal or human, can be used for any purpose including, e.g., the long-term modification and regulation of metabolic disorders, including prediabetes, obesity, insulin resistance, hyperinsulinemia, hyperglycemia and type 2 diabetes mellitus (T2DM) and/or, e.g., the treatment of other medical disorder(s) including immune or endocrine disorders or diseases. Bromocriptine citr...